AU2001291766A1 - Steroid hormones as transfer agents - Google Patents

Steroid hormones as transfer agents

Info

Publication number
AU2001291766A1
AU2001291766A1 AU2001291766A AU9176601A AU2001291766A1 AU 2001291766 A1 AU2001291766 A1 AU 2001291766A1 AU 2001291766 A AU2001291766 A AU 2001291766A AU 9176601 A AU9176601 A AU 9176601A AU 2001291766 A1 AU2001291766 A1 AU 2001291766A1
Authority
AU
Australia
Prior art keywords
steroid hormone
pharmaceutically active
active compound
hormone
progesterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291766A
Other languages
English (en)
Inventor
Charlotte Hauser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octagene GmbH
Original Assignee
Octagene GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octagene GmbH filed Critical Octagene GmbH
Publication of AU2001291766A1 publication Critical patent/AU2001291766A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001291766A 2000-08-15 2001-08-15 Steroid hormones as transfer agents Abandoned AU2001291766A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00202858A EP1180364A1 (fr) 2000-08-15 2000-08-15 Hormones stéroidiennes comme agents de transfert
EP00202858.7 2000-08-15
PCT/EP2001/009409 WO2002013791A2 (fr) 2000-08-15 2001-08-15 Hormones steroides utilisees comme agents de transfert.

Publications (1)

Publication Number Publication Date
AU2001291766A1 true AU2001291766A1 (en) 2002-02-25

Family

ID=8171921

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291766A Abandoned AU2001291766A1 (en) 2000-08-15 2001-08-15 Steroid hormones as transfer agents

Country Status (11)

Country Link
US (1) US20040028740A1 (fr)
EP (2) EP1180364A1 (fr)
JP (1) JP2004506006A (fr)
AU (1) AU2001291766A1 (fr)
CA (1) CA2419405A1 (fr)
CZ (1) CZ2003450A3 (fr)
HU (1) HUP0300753A2 (fr)
NZ (1) NZ524203A (fr)
PL (1) PL366042A1 (fr)
WO (1) WO2002013791A2 (fr)
ZA (1) ZA200301237B (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB951767A (en) * 1959-03-25 1964-03-11 Upjohn Co Improvements in or relating to pharmaceutical compositions and the preparation thereof
US3800038A (en) * 1972-04-21 1974-03-26 Biolog Concepts Inc Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier
GB1535531A (en) * 1976-10-15 1978-12-13 Warmer & Co Ltd W Pharmaceutical compositions
US5011678A (en) * 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances
US5574022A (en) * 1994-04-14 1996-11-12 The Center For Innovative Technology Method of attenuating physical damage to the spinal cord
US5599822A (en) * 1995-06-06 1997-02-04 Eli Lilly And Company Methods for minimizing bone loss
WO1998042185A1 (fr) * 1997-03-26 1998-10-01 Reprogen, Inc. Souris utilisees comme modele pour l'etude de l'endometriose
JP2002537311A (ja) * 1999-02-19 2002-11-05 オクタジーン・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ホルモン−ホルモン受容体の複合体および核酸構築物、並びに遺伝子治療におけるそれらの使用

Also Published As

Publication number Publication date
EP1311244A2 (fr) 2003-05-21
NZ524203A (en) 2004-12-24
JP2004506006A (ja) 2004-02-26
HUP0300753A2 (hu) 2003-09-29
ZA200301237B (en) 2004-02-16
WO2002013791A2 (fr) 2002-02-21
CA2419405A1 (fr) 2002-02-21
PL366042A1 (en) 2005-01-24
WO2002013791A3 (fr) 2003-02-13
CZ2003450A3 (cs) 2003-09-17
US20040028740A1 (en) 2004-02-12
EP1180364A1 (fr) 2002-02-20

Similar Documents

Publication Publication Date Title
JP6126072B2 (ja) 遺伝子発現を抑制する治療におけるリポソームによる効率的な送達のプロセスおよび組成物
KR101150242B1 (ko) 부신피질 자극 호르몬 유사체 및 관련 방법
CA2541498C (fr) Systeme d'administration a liberation controlee pour applications nasales
JP2000516209A (ja) カチオン性両親媒性物質／ｄｎａ複合体
JP2009502967A (ja) 粘膜送達を向上させるためのタイトジャンクション調節ペプチド化合物
JPS61501897A (ja) 融合リポソ−ムおよびリポソ−ムの酸誘導融合方法
TW200306801A (en) Farnesoid X-activated receptor agonists
WO1999040113A2 (fr) Lipopeptides contenant un fragment de l'interferon et leur utilisation dans des compositions pharmaceutiques
US20130156851A1 (en) Lipomacrocycles and uses thereof
CZ20023585A3 (cs) Léčba rakoviny
TW590775B (en) Pharmaceutical compositions for increasing or decreasing phagocytosis in mammalian cells
Jung-Testas et al. Two sex steroid receptors in mouse fibroblasts in culture
US20040028740A1 (en) Steroid hormones as transfer agents
Crettaz et al. Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells
JPH09100292A (ja) 酸化防止作用を有するステロイドを含有する、ヒトにおける薬物ホルモン代用のための製薬学的調剤
US20070154449A1 (en) Tight junction modulating peptides for enhanced mucosal delivery of therapeutic compounds
LT4441B (lt) Antigliukokortikoidinis vaistinis preparatas
KR100448298B1 (ko) 유전자발현의증진을위한글루코코르티코이드를포함하는약제학적조성물
Huang et al. Liposome and immunoliposome mediated delivery of proteins and peptides
JPWO2005054486A1 (ja) 遺伝子導入試薬調製法
WO2018207841A1 (fr) CORPS COMPOSITE, COMPOSITION SENSIBLE AU pH CONTENANT LE CORPS COMPOSITE, ET PROCÉDÉ DE PRODUCTION DU CORPS COMPOSITE
WO2008049620A1 (fr) Composition semi-solide à libération contrôlée
CA2093665A1 (fr) Vesicule renfermant un analogue phospholipidique
Huang et al. Liposome and Immunoliposome Mediated Delivery of Proteins and Peptides

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application